To hear contract research organization (CRO) INC Research tell it, the marriage between themselves and MDS Pharma's Phase II-IV operations, which INC just bought, is the greatest match ever made—a fit even more snug and cozy than those two sides of the yin-yang symbol. The deal closes today. “If we'd sat down before this and made out…more...

If you're flying into Bangalore, India you can expect to emerge into a modern airport. But don't expect a road that will get you from the airport to town. The government got the airport built, but not the road. Not yet. “That is typical of India, generally,” says Bob Scott-Edwards, president of Icon Central Laboratories, formerly with…more...

Brad Pitt and Angelina Jolie care about drug development? They suddenly hunger to learn more about sponsor-CRO partnerships, PDUFA and Critical Path, and thus they showed up at the Drug Information Association's (DIA) 45th annual meeting to drink it all in? They are curious about science in addition to being gorgeous, rich and fertile? Wait—those were actually…more...

In a major redesign of its flagship product for electronic data capture (EDC), Phase Forward has freshened up the user interface of one of the industry’s top packages. The changes are both cosmetic (no more red, green and yellow stoplight icons) and more structural. For fans of the stoplights, it's worth noting that some features of the…more...

etrials announced a new, unified way for users to log into and view three clinical systems. The new portal shows data from the firm's systems for electronic data capture; randomization and drug supply; and patient diaries. The company is also showing new patient diaries. One (the drop-proof Pidion BM-150R) is exclusively available through etrials. Here's .…more...

The regulatory system in India is maturing quickly. Just a few years ago, it was said to be in its infancy—with drug makers and contract research organizations (CROs) largely having to regulate themselves. Now it is an adolescent, and growing up fast. To explain where India's been and where it's going with respect to regulating clinical trials,…more...